A new law opens the door to a speedier approval process for new sunscreen actives; many of which have long been available to consumers outside of the U.S. In the U.S., sunscreen actives are regulated by the U.S. Food and Drug Administration (FDA) as drugs. Historically, the approval of new actives has been a lengthy process, with some applications awaiting the FDA’s decision for over a decade. This new law will ensure that FDA makes timely decisions on pending ingredients.
News Drill Down
- In a TIME magazine article Michael J. Werner, a member of the Public Access to Sunscreens (PASS) coalition described the legislation (which was pending at the time) as follows:”It is a win for the FDA because they are administering a process that works and they can have confidence that when they approve a product it is safe and effective. It will be a win for manufacturers because they will know that their products will be reviewed in a timely manner. And of course consumers will win because we will have more safe and effective sunscreens to choose from.”
- A Cosmetics Design article explains that there are 8 sunscreen ingredients awaiting approval from the FDA, including amiloxate, 10%; bemotrizinol, 10%; and bisoctrizole, 10%, among others.
- Time: New, Better Sunscreens Could Be Coming
- Time: Obama Signs Law for Better Sunscreens
- Cosmetics Design: It’s gone through! Obama signs Sunscreen Innovation Act
Full text of the Act and related information can be found here.
The views, opinions and technical analyses presented here are those of the author, and are not necessarily those of UL, ULProspector.com or Knowledge.ULProspector.com. While the editors of this site make every effort to verify the accuracy of its content, we assume no responsibility for errors made by the author, editorial staff or any other contributor. All content is subject to copyright and may not be reproduced without prior authorization from Prospector.